Dr. Shantala S. Sreerama, MD

Dr. Sreerama practices at Advocate Medical Group Beverly Outpatient Center in Chicago, Illinois.

Dr. Sreerama's NPI, 1295747061, was assigned on August 12, 2006. Dr. Sreerama holds Illinois license 036-096905.

Dr. Sreerama's primary practice is Advocate Medical Group Beverly Outpatient Center, at 9831 South Western Ave., Chicago, IL 60643. The practice phone is (773) 445-3500.

Dr. Sreerama's primary practice is Advocate Medical Group Beverly Outpatient Center in Chicago, Illinois. Dr. Sreerama is also affiliated with Advocate Trinity Hospital. The medical group on file is Dreyer Medical Clinic (Advocate Medical Group). Dmand AI also links Dr. Sreerama to 2 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account. Dr. Sreerama's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sreerama practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sreerama's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sreerama is licensed in Illinois.

CMS data shows 1,032 Medicare services from Dr. Sreerama across 16 procedure codes in 2024, for 182 Medicare patients. Medicare paid $72,411 for them. Every service was in an office.

CMS counts 182 Medicare patients who saw Dr. Sreerama in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sreerama's median patient age at 73, with 79% women.

In 2024, Dr. Sreerama wrote 12,036 Medicare Part D claims for 767 patients. 86% of them were for generic drugs. CMS names the drug for 11,427 of them, across 143 drugs with 11 or more claims each, at $1,093,667 in total drug cost. In 2023, CMS named 11,024 claims across 139 drugs.

Dr. Sreerama accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sreerama as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 5 general payments to Dr. Sreerama from 3 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $44.